August 7, 2008 - St. Jude Medical Inc. today said it received regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the Durata defibrillation lead, the company’s next-generation high-voltage lead.
